With an estimated 900,000 cases and 100,000 deaths annually in the United States, venous thromboembolism is the third most common cardiovascular cause of death, trailing only heart attacks and strokes. Existing treatments have significant limitations and requirements – high bleeding risks, lengthy treatment times, procedural complexities and extended hospital stays.
Akura Medical’s flagship product — the Akura Thrombectomy Catheter System — offers a unique solution that aims to address four key limitations of current-generation devices, namely navigation, target clot visualization, catheter clogging and tracking case progress.
Boasting a low-profile, steerable sheath, this user-friendly system incorporates bidirectional steering designed to enable physicians to precisely navigate complex vasculature. Physicians can deliver a small dose of contrast at any time during the procedure to visualize the area of interest and address clots without the need to cross them. The integrated aspiration and maceration technology, complemented by real-time data from pressure sensors, is designed to enable efficient removal of target clots and allow operators to detect changes in vascular pressure once a clot is removed.
Diagnostic and Interventional Cardiology – Akura Medical Closes $25 Million in A1 Financing to Develop New Thrombectomy System
Endovascular Today – The Akura Thrombectomy Catheter System for the Treatment of VTE
FINSMES – Akura Medical Closes $35M Series B Financing
JACC: Basic to Translational Science – A Differentiated Approach Delivering Targeted Thrombectomy for VTE: Clot Burden or Hemodynamics?
MassDevice – DeviceTalks: How Akura Medical Wants to Advance Thrombectomy
MassDevice – Shifamed’s Akura Medical Raises $35M for Thrombectomy System
Medical Device Network – Akura Medical Raises Funds for Mechanical Thrombectomy Platform
Medical Product Outsourcing – Akura Medical Closes $35M Series B Financing
MedTech Dive – Akura Medical Secures $35M to Pursue FDA Clearance for Thrombectomy Device
MedTech Strategist – Great Aspirations: New Medical Approaches to Treating Pulmonary Embolism
Venous News – Akura Medical Announces Successful First-in-Human Use of Its Mechanical Thrombectomy Platform
The Wall Street Journal – New Money: Akura Medical Closed $35 Million Series B
Transcatheter Cardiovascular Therapeutics Annual Meeting – Shark Tank Innovation Competition Finalist
Every year, American entrepreneurs start more than half a million companies. More than 90% of them will fail, with only 200 ever passing $100 million in revenue. At Unorthodox Ventures, we know how to reach $300 million. Jump in with us.
